General CatalystTHE DEAL, AT A GLANCE
From the announcementWellTheory
What it doesWellTheory is a Digital Health company focused on Expand Autoimmune Care Platform.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Who is involvedBacked by General Catalyst, new, including <strong>7wire Ventures, Ingeborg InvestmentsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedWellTheory raised $14M Series A, announced 2025-10-14From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersWellTheory's $14M Series A is a lower-quartile Healthcare & Life Sciences financing in an active market, with sector validation coming from General Catalyst rather than…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
WellTheory · Financing Record
Explore source-linked visual explanations for WellTheory. Unsupported claims are withheld while source review continues.
Record 2621 · Recorded date: 2025-10-14
Explore company records →